Treatment of CGD-associated Colitis with the IL-23 Blocker Ustekinumab

J Clin Immunol. 2016 Oct;36(7):619-20. doi: 10.1007/s10875-016-0318-x. Epub 2016 Jul 27.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Colitis / drug therapy*
  • Colitis / etiology
  • Granulomatous Disease, Chronic / complications*
  • Humans
  • Interleukin-12 / antagonists & inhibitors
  • Interleukin-23 / antagonists & inhibitors
  • Male
  • Ustekinumab / therapeutic use*

Substances

  • Interleukin-23
  • Interleukin-12
  • Ustekinumab